Defibrillators Market by product and End User - Global Forecast 2022

According to the new market research report Defibrillators Market is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%. Factors such as technological advancements in defibrillators, increasing burden of target diseases, growing focus on providing public-access defibrillators, and rising number of training & awareness programs on defibrillators are driving the growth of this market.

Read More: https://www.marketsandmarkets.com/PressReleases/automated-external-defibrillator.asp

The report analyzes the global market by product, end user, and region.

The implantable cardioverter defibrillators (ICDs) segment is expected to account for the largest share of the defibrillators market, by product type, in 2017

On the basis of products, the market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into manual external defibrillators, automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs).

This report covers the defibrillators market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising incidence of target diseases in the region, technological advancements in defibrillators, and increasing number of public defibrillation programs in the region. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=549

North America dominated the global defibrillators market in 2017

The large share of the North American market can mainly be attributed to the continuous technological advancements and product innovations, increasing number of public defibrillation programs, and rising focus of key players to expand their business in the North American region.

ZOLL Medical (US) held the leadership position in the global external defibrillators market. The company adopted new product launches, agreements, and partnerships as its core business strategies to enhance its share in the global external market. Other prominent players in the global external market included Philips (Netherlands), Physio-Control (US), Cardiac Science (US), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey).

Elastography Imaging Market Growing at a CAGR of 11.0%

According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period. The growth of this market is mainly driven by the growing incidence of breast cancer and chronic liver diseases and a rising preference for minimally invasive procedures across the globe. However, the high cost of elastography imaging systems and an unfavorable reimbursement scenario are expected to restrain the growth of this market to a certain extent.

Read more: https://www.marketsandmarkets.com/PressReleases/elastography-imaging.asp

The major elastography imaging vendors include GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Canon Medical System Corporation (Japan), Samsung Medison (South Korea), Hitachi Ltd. (Japan), Shenzhen Mindray Bio-Medical Electronics Co. (China), FUJIFILM Holdings Corporation (Japan), Esaote (Italy), SuperSonic Imagine (France), and Resoundant (US).These players have adopted various growth strategies from 2016 to 2018, such as product launch, collaboration, partnership, acquisitions and expansions to expand their presence in the global elastography imaging market. This has helped them to innovate their offerings and broaden their customer base.

GE Healthcare is one of the leading companies in the elastography imaging systems. The company focuses on maintaining its leading position in the elastography imaging market through pipeline development and product commercialization. It has a strong presence and wide industry coverage in North America, South America, Europe, Australia, and Asia. The company has a reliable customer- services support set up, which helps in strengthening its customer relationships and growing its geographical presence. The company is expected to grow at a positive rate in the market due to its superior product offerings.

Philips Healthcare is among the top players operating in the global elastography imaging market. The company focuses on developing advanced elastography imaging systems and expanding its geographical presence in order to maintain its position in the elastography imaging market. Philips Healthcare manufactures its products in 25 countries and distributes these products in over 100 countries, on a global scale.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107232051

The market is divided into four major regions - North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, Europe is expected to account for the largest share of this market, followed by North America. The large share of this regional segment is attributed to ongoing clinical research projects in elastography, the early commercialization of these devices in the region, and the significant healthcare expenditure across mature European countries. Furthermore, government initiatives for cancer screening, which involve the use of ultrasound systems featuring elastography, are also supporting market growth.

Medical Device Contract Manufacturing Market - Jabil Inc. (US) and Flex Ltd. (Singapore) Dominate the Market

According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%. Market growth is largely driven by the rising global disease prevalence, life expectancy, and geriatric population. Newer and advanced technologies necessitate the incorporation of advanced manufacturing methods, which result in increased overall costs.
While major players with sufficient resources can update their manufacturing processes to accommodate such changes, small and medium-sized manufacturers must look for contract manufacturers to save costs. Dynamic small and medium start-up companies are also turning to third-party contract manufacturers to reduce their start-up and internal costs and expedite the time-to-market of their products. This focus on manufacturing agility and flexibility to reduce costs and accelerate the time-to-market, as well as the need to maintain constant innovation, is driving the demand for contract manufacturing services.
The medical device contract manufacturing market is segmented on the basis of device type, service, class of device, and region.
Read More: https://www.marketsandmarkets.com/PressReleases/medical-device-contract-manufacturing.asp
On the basis of device type, cardiovascular devices and endoscopy devices are both projected to witness the highest growth during the forecast period between 2019 and 2024. The increasing prevalence of cardiovascular diseases is expected to increase the demand for cardiovascular devices in hospitals, diagnostic laboratories, and home care settings. The volume growth of cardiovascular devices, coupled with an increasing number of medical device companies opting for contract manufacturing services in order to reduce the cost of manufacturing, is expected to drive the market for cardiovascular devices during the forecast period.
By service, the final goods assembly services segment is expected to witness the highest growth during the forecast period. Market growth is largely driven by the increasing need for these services by various OEMs, medical device companies, and pharmaceutical companies that are involved in the manufacturing and sales of fully integrated single-use medical devices.
Based on the class of device, the market is broadly segmented into Class I, Class II, and Class III medical devices. The Class III medical devices segment is expected to register the highest growth during the forecast period due to the rising demand for pacemakers, implants, and ventilators. In addition to this, the manufacturing of Class III devices requires sophisticated and advanced technologies that can be a budgetary concern for small and medium-sized medical device companies.
OEMs are increasingly opting to outsource their technical and production services to contract manufacturing organizations (CMOs) to reduce their manufacturing footprint. Outsourcing the production of various components in a medical device allows manufacturers to be more dynamic and cost-effective in their production process. The consolidation of OEMs has encouraged CMOs to follow the trend and also consolidate to expand their capabilities and form strategic partnerships with their OEM customers.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851
Geographically, the Asia Pacific is expected to witness the highest CAGR during the forecast period, owing to factors such as the increasing demand for medical devices in this region due to the improving healthcare infrastructure, adoption of technologically advanced products, low cost of manufacturing, and the less stringent regulatory scenario for manufacturing of medical devices which promotes higher usage of medical devices as compared to most developed countries.

Wearable Medical Devices Market worth $32.71 billion by 2027

According to research report the report "Wearable Medical Devices Market by Device (Diagnostic (Heart, Pulse, BP, Sleep), Therapeutic (Pain, Insulin, Rehabilitation)), Application (Sport, Fitness, RPM), Type (Smartwatch, Patch), Distribution Channel (Pharmacy, Online) - Global Forecast to 2027", is expected to reach USD 32.71 billion by 2027 from USD 6.22 billion in 2017, at a CAGR of 18.3%. The growth of the market is attributed to the technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, and increasing awareness about physical fitness.
Know More: https://www.marketsandmarkets.com/PressReleases/wearable-medical-device.asp
Activity monitors are expected to dominate the market in 2017.
Based on type, the wearable medical devices market is segmented into activity monitors, smartwatches, smart clothing, and patches. In 2017, the activity monitors segment is expected to account for the largest share of the wearable medical devices market. The high growth in this segment is attributed to factors such as the rising adoption of sedentary and unhealthy lifestyles, rising prevalence of lifestyle diseases, and growing awareness of health and fitness.
Based on application, the sports and fitness segment is projected to grow at the highest CAGR during the forecast period.
Based on application, the wearable medical devices market is segmented into sports and fitness, remote patient monitoring, and home healthcare. The sports and fitness segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing focus on physical fitness among people to improve the quality of life, coupled with the growing trend of tracking health progress.
North America to dominate the wearable medical devices market in 2017
In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to the presence of developed healthcare infrastructure, focus on technological advancements, and the development of interconnected and highly advanced healthcare apps and compatible devices, and the presence of key market players.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973
The wearable medical devices market is highly competitive with several big and small players. Prominent players in this market include Fitbit (US), Philips (Netherlands), LifeWatch (Switzerland), Garmin (Switzerland), and Omron (Japan). The other players operating in this market include Drägerwerk (Germany), Nokia Technologies (US), Jawbone (US), Polar (Finland), Wor(l)d Global Network (US), Activeinsights (UK), VitalConnect (US), Xiaomi (China), Misfit (US), and Monica Healthcare (UK).

EMS Products Market Leading Players and Growth Factors

According to the new market research report EMS Products Market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%.

Factors driving the growth of this market include high demand for emergency care, increasing incidence of trauma injuries, and growing investments by government bodies on healthcare infrastructure development (including the establishment of and improvements in emergency care infrastructure.

Read More: https://www.marketsandmarkets.com/PressReleases/ems-product.asp

The EMS products market is consolidated in nature due to the presence of a large number of players. The key players in the market are Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C.R. Bard (US).

The key strategies followed by most companies in the EMS products market are agreements, expansions, and product launches. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2017. Some of the leading players who adopted these strategies include Becton, Dickinson (US), Medtronic (Ireland), and 3M (US).

Cardinal Health held the largest share of the EMS products market in 2016. Cardinal Health developments and manufactures medical and surgical products and provides customized health care solutions to hospitals, ASCs, clinical laboratories, pharmacology, and physicality. and anesthesia supplies. The company has mainly focused on acquisition to increase its share in this market. For instance, in March 2015, Cardinal Health acquired Johnson & Johnsons (US ) Cordis business.

Medtronic, which held the second-largest share in the EMS products market in 2016, is one of the leading providers of innovative and advanced medical technologies and solutions across the globe. Medtronic is nottable for its 2015 acquisition of Covidien (Irelandly, which, A focus on product development and acquisition, along with its strong geographic presence, has helped maintain its leading position in the market. It has 32 sales organizations and 13 production sites in North America, Europe, and Australia.

Johnson & Johnson held the third-largest share in the EMS products market in 2016. Its subsidiary, Ethicon, offers various solutions for healthcare professionals and patients to provide better treatments and optimize outcomes. The company offers a wide range of limits The company focuses on expanding its geographic presence to enhance its customer base, especially in emerging countries. The company focuses on expanding its geographic focus on aesthetics, women's health, urology, and general surgery.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195094847

It offers a wide range of products, including temperature management products, emergency and transport stretchers, personal protective equipment medical beds, and other emergency equipment. Stryker initiations and product portfolio.

GE Healthcare has the fifth position in the EMS market. GE Healthcare has focused on Inorganic strategies for growth, as well as product development. The company is engaged in providing medical technologies and professional consulting solutions that help in promoting its wide geographic presence has helped strength its customers base.

Pacemakers Market Top Players and Growth Strategies

According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period. The major driving factors in the pacemakers market are increasing prevalence of cardiovascular diseases and technological advancements in devices.
Read More: https://www.marketsandmarkets.com/ResearchInsight/pacemaker-market.asp
The major pacemaker’s vendors include Medtronic (Ireland), Abbott (US), and Boston Scientific (US) BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China). These players have adopted various growth strategies such as expansions, acquisitions, and new product launches to expand their presence in the global pacemakers market. Product launches has been the most dominating strategy adopted by major players from 2015 to 2018. This has helped them to expand their consumer base and address the unmet needs of end users.
In line with rising adoption of pacemaker devices, Medtronic focus on to develop innovative products for the treatment of heart rhythm disorders and heart failures. The company offers an extensive product portfolio for this market through its Cardiac and Vascular Group segment. It has a significant presence in more than 155 countries including major markets such as the US and Ireland. Medtronic focuses on organic growth strategies such as product launches to remain competitive in the market. In the last three years, it launched several products such as the Advisa and Ensura SR MRI SureScan Single-chamber Pacemaker Devices, Viva CRT-P Pacemaker, and Advisa DR MRI SureScan Pacing System.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243344814
In 2017, Abbott acquired of St Jude Medical, this acquisition strengthened Abbott’s product offerings in the cardiovascular devices segment including pacemakers. The company offers a wide range of pacemaker products for cardiac rhythm management applications. Abbott is focusing on inorganic and organic growth strategies such as acquisitions and product launches. For example, in 2018, the company launched its smallest pacemaker, Assurity MRI and also receive CE mark approval for Nanostim leadless pacemaker in 2016. The company has a vast geographic presence and operated in 150 countries across the world. Abbott’s strong portfolio provides it with a competitive advantage in the market.

X-Ray Detectors Market Top Players and Growth Strategies

X-ray detectors market

According to research report the global X-Ray Detector Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period. Market growth is mainly driven by the growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays.

Read More: https://www.marketsandmarkets.com/PressReleases/x-ray-detectors.asp

The X-ray detectors market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1%. Market growth is largely driven by growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays. The introduction of wireless X-ray detectors, growing medical tourism in developing countries, and the emerging markets are expected to provide a wide range of growth opportunities for players in the market. On the other hand, the high cost of digital X-ray systems is a major factor limiting market growth.

The X-ray detectors market is highly consolidated in nature with several big and emerging players. Prominent players in this market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), Teledyne DALSA Inc. (US), Fujifilm Holding Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Hamamatsu Photonics K.K. (Japan), Analogic Corporation (US), and Rayence (South Korea). These players have adopted various strategies such as acquisitions, partnerships, collaborations, and product launches to further expand their presence in the global X-ray detectors market. Acquisitions were the key growth strategies adopted by top players such as Varex Imaging Corporation (US), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), and Agfa-Gevaert Group (Belgium) from 2016 to 2018.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984

Varian Medical Systems dominated the X-ray detectors market in 2018. The company has managed to create a unique identity in this market due to its robust product portfolio and large geographic presence. In addition, the company also focuses on organic and inorganic growth strategies such as expansions, acquisitions, and agreements. For instance, in December 2016, the company acquired PerkinElmer's medical imaging business (US), a manufacturer of diagnostic imaging products. The company also focuses on geographic expansions to maintain its leading position in the market. For instance, in March 2016, the company opened the Wuxi Regional Service Center in China.

Trixell (Division of Thales Group) is among the major player in the X-ray detectors market for FPDs. It is a joint venture of Philips Medical Systems, Siemens Medical, and Thales Electron Devices. The company‘s large market share is attributed to its exhaustive product portfolio of X-ray detectors. The company has been active in the market for more than 15 years and is a pioneer in WiFi FPD technology. The company believes in investing in product development and strengthening its solutions-based business. For instance, in November 2016, the company launched the Pixium Portable 3543 DR detector. The innovation-centric company invests heavily in R&D to maintain its market share. It invested USD 912.1 million and USD 812.0 million in R&D in 2017 and 2016, respectively.

Elastography Imaging Market – Top Leader and Growth Strategies

Elastography Imaging Market

According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period.

The growth of the global elastography imaging market is mainly driven by the growing incidence of breast cancer and chronic liver diseases, and a rising preference for minimally invasive procedures across the globe. Emerging economies will provide new growth opportunities for players in the elastography imaging market.

The major elastography imaging vendors include GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Canon Medical System Corporation (Japan), Samsung Medison (South Korea), Hitachi Ltd. (Japan), Shenzhen Mindray Bio-Medical Electronics Co. (China), FUJIFILM Holdings Corporation (Japan), Esaote (Italy), SuperSonic Imagine (France), and Resoundant (US).These players have adopted various growth strategies from 2016 to 2018, such as product launch, collaboration, partnership, acquisitions and expansions to expand their presence in the global elastography imaging market. This has helped them to innovate their offerings and broaden their customer base.

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107232051

GE Healthcare is one of the leading companies in the elastography imaging systems. The company focuses on maintaining its leading position in the elastography imaging market through pipeline development and product commercialization. It has a strong presence and wide industry coverage in North America, South America, Europe, Australia, and Asia. The company has a reliable customer- services support set up, which helps in strengthening its customer relationships and growing its geographical presence. The company is expected to grow at a positive rate in the market due to its superior product offerings.

Philips Healthcare is among the top players operating in the global elastography imaging market. The company focuses on developing advanced elastography imaging systems and expanding its geographical presence in order to maintain its position in the elastography imaging market. Philips Healthcare manufactures its products in 25 countries and distributes these products in over 100 countries, on a global scale.

The market is divided into four major regions - North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, Europe is expected to account for the largest share of this market, followed by North America. The large share of this regional segment is attributed to ongoing clinical research projects in elastography, the early commercialization of these devices in the region, and the significant healthcare expenditure across mature European countries. Furthermore, government initiatives for cancer screening, which involve the use of ultrasound systems featuring elastography, are also supporting market growth.

Read More: https://www.marketsandmarkets.com/PressReleases/elastography-imaging.asp